Losartan

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

105 API Suppliers, 46 USDMF, 36 CEP/COS, 19 JDMF, 28 EU WC, 71 KDMF, 19 NDC API, 56 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

23 Suppliers

23 Suppliers

DOSSIERs // Finished Dosage Formulations

841 Dossiers, 125 FDA Orange Book, 443 Europe, 45 Canada, 66 South Africa, 162 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 100MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG, TABLET;ORAL - 12.5MG;100MG, TABLET;ORAL - 12.5MG;50MG, TABLET;ORAL - 25MG;100MG

TABLET;ORAL - 100MG
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG
TABLET;ORAL - 12.5MG;100MG
TABLET;ORAL - 12.5MG;50MG
TABLET;ORAL - 25MG;100MG

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 23 BASF, 22 Roquette, 16 Microlex e.U, 16 SPI Pharma, 12 Sigachi Industries, 11 Gangwal Healthcare, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 8 Gangwal Chemicals, 7 Nanjing Well Pharmaceutical, 7 Ideal Cures Pvt Ltd, 7 Seppic, 7 DFE Pharma, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ingredion Pharma Solutions, 4 Vasa Pharmachem, 4 Prachin Chemical, 3 Actylis, 3 Pharmatrans-Sanaq, 3 Kima Chemical, 2 Clariant, 2 Nomisma Healthcare, 2 DKSH, 2 The Dow Chemical Company, 2 Seqens, 2 Finar, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Ulanqab Kema New Material, 1 Jai Radhe Sales, 1 ACG Worldwide, 1 Qualicaps, 1 Pfanstiehl, 1 Rochem International Inc, 1 Boai NKY Pharmaceuticals Ltd, 1 Aeon Procare, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 39 Direct Compression, 33 Disintegrants & Superdisintegrants, 32 Controlled & Modified Release, 25 Granulation, 23 Thickeners and Stabilizers, 20 Lubricants & Glidants, 19 Film Formers & Plasticizers, 16 Taste Masking, 16 Topical, 15 Chewable & Orodispersible Aids, 15 Co-Processed Excipients, 14 Solubilizers, 14 Parenteral, 6 API Stability Enhancers, 5 Empty Capsules, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 374 Finished Drug Prices

MARKET PLACE

33 APIs, 8 DOSSIERS // FDF

PATENTS

6 Health Canada Patents

6 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 3 EDQM Standards, 4 USP Standards, 6 JP Standards, 12 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilations & Company Tracker #PharmaFlow, 116 News

List of Suppliers

Full Screen View

Reset Filter

Price Info

Zhuhai Rundu Pharmaceutical Co.,Ltd

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

2-ButyI-5-chIoro-1H-imidazoIe-4-carboxaIdehyde

PDF Supplier PDF

URL Supplier Web Content

CAS Number

83857-96-9

End Use API

Losartan Potassium

About The Company

Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise ...

Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug research and development, production, and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province. It was established in 1999. On January 5, 2018, the company was listed on the Shenzhen Stock Exchange (stock abbreviation: Rundu; stock code: 002923). The company's main business is the research and development, production, and sales of chemical-pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates. field.

ASK
US